Showing results (31-40 of 334) with videos related to

Sort By:
Pageof 34
JAMA Cardiology|July 28, 2020
Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH TrialNelson Wang, Abdul Salam, Ruth Webster, et al.
Plos One|June 8, 2011
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk, Anthony Rodgers, Anushka Patel, et al.
International Journal of Cardiology|August 19, 2021
Halving cardiovascular risk with combined blood pressure and cholesterol lowering - Why are we not there yet?Nelson Wang, Mark D Huffman, Johan Sundström, et al.
Lancet (London, England)|May 6, 2008
Global burden of blood-pressure-related disease, 2001Carlene M M Lawes, Stephen Vander Hoorn, Anthony Rodgers, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 3, 2010
Electrochemically controlled drug delivery based on intrinsically conducting polymersDarren Svirskis, Jadranka Travas-Sejdic, Anthony Rodgers, et al.
Circulation. Cardiovascular Quality and Outcomes|April 18, 2022
Compounding Benefits of Cholesterol-Lowering Therapy for the Reduction of Major Cardiovascular Events: Systematic Review and Meta-AnalysisNelson Wang, Mark Woodward, Mark D Huffman, et al.
International Journal of Preventive Medicine|April 2, 2026
The Association Between Migraine and Type 2 Diabetes Mellitus: A Narrative ReviewFaraidoon Haghdoost, Abdul Salam, Anthony Rodgers, et al.
The Medical Journal of Australia|December 16, 2014
An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trialTracey-Lea Laba, Alison Hayes, Serigne Lo, et al.
BMJ Open|June 27, 2025
Process evaluation of a randomised trial of a triple low-dose combination pill strategy to improve hypertension control: a qualitative studyAbdul Salam, Tracey Laba, Rupasvi Dhurjati, et al.
Implementation Science : IS|September 25, 2016
An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: protocol for a cluster randomized controlled trialAdina Hayek, Rohina Joshi, Tim Usherwood, et al.
Pageof 34